Skip to main content
. 2022 Jan 10;182(3):1–9. doi: 10.1001/jamainternmed.2021.7556

Table 2. Characteristics of Participants.

Characteristic Participants, No. (%)
Intervention (n = 265) Control (n = 274)
Age, mean (SD), y 75.9 (7.3) 78.0 (8.2)
Female 124 (46.8) 145 (52.9)
Living in community 260 (98.1) 258 (94.2)
Elective admission 66 (24.9) 26 (9.5)
Surgical procedure 87 (32.8) 29 (10.6)
Frailty index, mean (SD) 0.2 (0.1) 0.3 (0.2)
Charlson Comorbidity Index score, median (IQR) 2.0 (1.0-3.0) 2.0 (1.0-3.0)
Comorbidities
Hypertension 152 (57.4) 166 (60.6)
Chronic obstructive airway disease 119 (44.9) 102 (37.2)
Arthritis or rheumatic condition 81 (30.6) 83 (30.3)
Cancer 76 (28.7) 57 (20.8)
Arrhythmia 68 (25.7) 94 (34.3)
Type 1 or 2 diabetes 56 (21.1) 70 (25.5)
Peripheral vascular disease 46 (17.4) 39 (14.2)
Cerebrovascular disease 34 (12.8) 42 (15.3)
Heart failure 30 (11.3) 53 (19.3)
Previous myocardial infarction 25 (9.4) 40 (14.6)
No. of medications at admission, mean (SD) 7.2 (4.4) 8.1 (4.8)
Dependent in ≥1 basic ADL 2 wk before admission 37 (14.0) 81 (29.6)
Dependent in ≥1 instrumental ADL 2 wk prior to admission 171 (64.5) 194 (70.8)
Urinary incontinence 2 wk before admission 40 (15.1) 44 (16.1)
Fecal incontinence 2 wk before admission 27 (10.2) 32 (11.7)
Hospital admission in previous 12 mo 113 (42.6) 137 (50.0)
Fall in previous 6 mo 88 (33.2) 114 (41.6)
Malnutrition risk (Malnutrition Screening Tool score ≥2) 96 (36.2) 121 (44.2)
SPMSQ score at admission, mean (SD) 8.2 (2.0) 7.3 (2.4)

Abbreviations: ADL, activities of daily living; SPMSQ, Short Portable Mental Status Questionnaire (a score of <8 represents cognitive impairment).